Viktoría Werkström

4.0k total citations · 3 hit papers
32 papers, 2.9k citations indexed

About

Viktoría Werkström is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Viktoría Werkström has authored 32 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Urology. Recurrent topics in Viktoría Werkström's work include Asthma and respiratory diseases (15 papers), Allergic Rhinitis and Sensitization (8 papers) and Urinary Bladder and Prostate Research (8 papers). Viktoría Werkström is often cited by papers focused on Asthma and respiratory diseases (15 papers), Allergic Rhinitis and Sensitization (8 papers) and Urinary Bladder and Prostate Research (8 papers). Viktoría Werkström collaborates with scholars based in Sweden, United States and Japan. Viktoría Werkström's co-authors include Peter Barker, Geoffrey Gilmartin, Mitchell Goldman, Eugene R. Bleecker, Stephanie Sproule, J. Mark FitzGerald, Magnus Aurivillius, Steven F. Weinstein, Alberto Papi and Pascal Chanez and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and The Journal of Urology.

In The Last Decade

Viktoría Werkström

31 papers receiving 2.9k citations

Hit Papers

Benralizumab, an anti-interleukin-5 receptor α monoclonal... 2016 2026 2019 2022 2016 2016 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
    2016 984 citations J. Mark FitzGerald, Eugene R. Bleecker et al. The Lancet profile →
  2. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    2016 976 citations Eugene R. Bleecker, J. Mark FitzGerald et al. The Lancet profile →
  3. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
    2021 205 citations Claus Bachert, Joseph K. Han et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktoría Werkström Sweden 17 2.1k 1.4k 615 565 505 32 2.9k
A Riccio Italy 34 1.6k 0.8× 888 0.6× 1.2k 1.9× 251 0.4× 570 1.1× 128 3.1k
R. Robert Schellenberg Canada 29 1.4k 0.7× 992 0.7× 544 0.9× 245 0.4× 360 0.7× 91 2.5k
Florence Schleich Belgium 28 2.0k 1.0× 1.5k 1.1× 378 0.6× 466 0.8× 706 1.4× 134 2.9k
Janet Rimmer Australia 24 670 0.3× 450 0.3× 745 1.2× 326 0.6× 123 0.2× 81 1.6k
Jordi Roca‐Ferrer Spain 28 1.2k 0.6× 536 0.4× 674 1.1× 394 0.7× 295 0.6× 81 2.3k
Gail M. Gauvreau Canada 44 5.1k 2.5× 2.6k 1.8× 2.0k 3.2× 1.3k 2.3× 2.6k 5.2× 188 6.8k
Robert M. Naclerio United States 24 1.6k 0.7× 599 0.4× 1.3k 2.1× 392 0.7× 296 0.6× 60 2.6k
Steven R. Findlay United States 27 1.2k 0.6× 618 0.4× 1.0k 1.7× 92 0.2× 297 0.6× 53 1.9k
Anna Bodzenta­‐Łukaszyk Poland 27 1.2k 0.6× 870 0.6× 366 0.6× 119 0.2× 536 1.1× 128 2.2k
Dirkje S. Postma Netherlands 32 2.0k 1.0× 1.3k 0.9× 602 1.0× 272 0.5× 784 1.6× 66 3.0k

Countries citing papers authored by Viktoría Werkström

Since Specialization
Citations

This map shows the geographic impact of Viktoría Werkström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktoría Werkström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktoría Werkström more than expected).

Fields of papers citing papers by Viktoría Werkström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktoría Werkström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktoría Werkström. The network helps show where Viktoría Werkström may publish in the future.

Co-authorship network of co-authors of Viktoría Werkström

This figure shows the co-authorship network connecting the top 25 collaborators of Viktoría Werkström. A scholar is included among the top collaborators of Viktoría Werkström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktoría Werkström. Viktoría Werkström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wedner, H. James, Takao Fujisawa, Theresa W. Guilbert, et al.. (2024). Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety ( TATE study). Pediatric Allergy and Immunology. 35(3). e14092–e14092. 16 indexed citations
2.
Cheung, TT, Yen Lin Chia, Chi‐Ho Lee, et al.. (2023). Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants. Drug Design Development and Therapy. Volume 17. 209–218. 4 indexed citations
3.
Shih, Vivian H., Ashley F. Slagle, Cristina Ivanescu, et al.. (2023). Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary. Annals of Otology Rhinology & Laryngology. 132(12). 1638–1648. 1 indexed citations
4.
Bachert, Claus, Joseph K. Han, Martin Y. Desrosiers, et al.. (2021). Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 149(4). 1309–1317.e12. 205 indexed citations breakdown →
5.
FitzGerald, J. Mark, Eugene R. Bleecker, Parameswaran Nair, et al.. (2016). Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 388(10056). 2128–2141. 984 indexed citations breakdown →
6.
FitzGerald, J Mark, Parameswaran Nair, Stephanie Korn, et al.. (2016). LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial. OA1969–OA1969. 2 indexed citations
7.
Werkström, Viktoría, et al.. (2016). Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology. 119(6). 574–581. 8 indexed citations
8.
Bleecker, Eugene R., J. Mark FitzGerald, Pascal Chanez, et al.. (2016). Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. The Lancet. 388(10056). 2115–2127. 976 indexed citations breakdown →
9.
Berg, Tove, Marita Olsson, Janeric Seidegård, et al.. (2014). Gene expression analysis of membrane transporters and drug‐metabolizing enzymes in the lung of healthy andCOPDsubjects. Pharmacology Research & Perspectives. 2(4). e00054–e00054. 19 indexed citations
10.
Werkström, Viktoría, et al.. (2009). Vardenafil‐induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder. British Journal of Urology. 104(11). 1740–1745. 19 indexed citations
11.
Werkström, Viktoría, et al.. (2008). VARDENAFIL RELAXES PRECONTRACTED RAT DETRUSOR PARTIALLY THROUGH UROTHELIUM-DEPENDENT MECHANISMS. European Urology Supplements. 7(3). 264–264. 1 indexed citations
12.
Pettersson, Jonas, Ulf Hindorf, Paula Persson, et al.. (2007). Muscular exercise can cause highly pathological liver function tests in healthy men. British Journal of Clinical Pharmacology. 65(2). 253–259. 249 indexed citations
13.
Werkström, Viktoría, Anna Svensson, Karl‐Erik Andersson, & Petter Hedlund. (2006). Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. British Journal of Urology. 98(2). 414–423. 62 indexed citations
14.
Werkström, Viktoría & Karl‐Erik Andersson. (2005). ATP‐ and adenosine‐induced relaxation of the smooth muscle of the pig urethra. British Journal of Urology. 96(9). 1386–1391. 11 indexed citations
15.
Giraldi, Annamaria, et al.. (2002). Morphological and functional characterization of a rat vaginal smooth muscle sphincter. International Journal of Impotence Research. 14(4). 271–282. 55 indexed citations
16.
Giraldi, Annamaria, et al.. (2001). Effects of diabetes on neurotransmission in rat vaginal smooth muscle. International Journal of Impotence Research. 13(2). 58–66. 57 indexed citations
17.
Werkström, Viktoría, et al.. (2000). In vitro contractile responses of detrusor to carbachol and neurokinin A, in children with recurrent urinary tract infection or day wetting. British Journal of Urology. 85(3). 319–325. 9 indexed citations
18.
Werkström, Viktoría, et al.. (1998). Inhibitory innervation of the guinea-pig urethra; roles of CO, NO and VIP. Journal of the Autonomic Nervous System. 74(1). 33–42. 27 indexed citations
19.
Werkström, Viktoría, Katarina Persson, & Karl‐Erik Andersson. (1997). NANC transmitters in the female pig urethra–localization and modulation of release via α2‐adrenoceptors and potassium channels. British Journal of Pharmacology. 121(8). 1605–1612. 19 indexed citations
20.
Werkström, Viktoría, et al.. (1995). Factors involved in the relaxation of female pig urethra evoked by electrical field stimulation. British Journal of Pharmacology. 116(1). 1599–1604. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Riccio Breakdown of academic impact, for papers by R. Robert Schellenberg Breakdown of academic impact, for papers by Florence Schleich Breakdown of academic impact, for papers by Janet Rimmer Breakdown of academic impact, for papers by Jordi Roca‐Ferrer Breakdown of academic impact, for papers by Gail M. Gauvreau Breakdown of academic impact, for papers by Robert M. Naclerio Breakdown of academic impact, for papers by Steven R. Findlay Breakdown of academic impact, for papers by Anna Bodzenta­‐Łukaszyk Breakdown of academic impact, for papers by Dirkje S. Postma
Rankless by CCL
2026